Suntrust Banks’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
Sell
-6,050
Closed -$250K 1315
2017
Q2
$250K Sell
6,050
-1
-0% -$38 ﹤0.01% 1128
2017
Q1
$213K Sell
6,051
-1,310
-18% -$41.5K ﹤0.01% 1169
2016
Q4
$226K Sell
7,361
-5,171
-41% -$160K ﹤0.01% 1409
2016
Q3
$377K Buy
12,532
+407
+3% +$12.3K ﹤0.01% 1091
2016
Q2
$330K Sell
12,125
-63
-0.5% -$1.61K ﹤0.01% 1119
2016
Q1
$326K Buy
+12,188
New +$298K ﹤0.01% 1093

Other funds holding RGEN

Suntrust Banks's RGEN Position: Q3 2017 in Review

Suntrust Banks sold out of Repligen (RGEN) in Q3 2017, closing a stake of 6,050 shares — an estimated $250K sold.

Suntrust Banks first reported a position in RGEN in Q1 2016 and held it in 6 quarters. The position peaked at $377K in Q3 2016. 190 funds tracked by Wall St. Rank hold RGEN as of Q3 2017.

  • Suntrust Banks reported no remaining Repligen position as of Q3 2017 after selling out during the quarter.
  • Suntrust Banks sold 6,050 Repligen shares in Q3 2017, an estimated $250K.
  • Suntrust Banks first reported a position in Repligen in Q1 2016 and held it in 6 quarters.
  • Suntrust Banks's Repligen position peaked at $377K in Q3 2016.
  • 190 funds tracked by Wall St. Rank held Repligen as of Q3 2017.

Based on Suntrust Banks's 13F filing for Q3 2017, filed 14 Nov 2017.